Presentations

Inmedix Presentations: Past and Future

Upcoming Presentations

October 26, 2017.  Two lectures at the Outsourcing in Clinical Trials, Pacific Northwest 2017 meeting in Seattle, WA.  “Development of Stress Diagnostics and What This Will Mean for Future Clinical Trials” and “Cost and Resource Conscience Clinical Funding for the Start-up Biotech Venture.” 

November 6, 2017.  American College of Rheumatology annual meeting, San Diego, CA. November 4-9, 2017.  Abstract: Heart rate variability testing with autonomic nervous system optimization: Could it change the course of spending for rheumatoid arthritis patients in the U.S.? An exploratory economic modeling minimal model analysis.

November 14, 2017.  Inmedix company presentation at Biotech & Money Investival Showcase, London


Selected Past Presentations

September, 2017.  RESI Boston 2017. Marriott Copley Place, Boston.

January, 2017.  "Autonomic neuroregulation of rheumatoid arthritis: a paradigm shift in therapeutic strategy”, Rheumatology Grand Rounds, Brigham & Women’s Hospital, Boston.

November, 2016.  "Autonomic neuroregulation of autoimmune disease" Study Group Co-chair with Paul-Peter Tak MD PhD.  American College of Rheumatology annual meeting, Washington, DC.

November, 2015.  "Autonomic neuroregulation of rheumatoid arthritis" Study Group Co-chair with Paul-Peter Tak, MD PhD.  American College of Rheumatology annual meeting, San Francisco.

November 2014.  “Fibromyalgia and positional cervical cord compression (PC3)”, 2014 Primary Care Update, Phoenix.

April, 2012.  “Practical management approaches to fibromyalgia”, Colorado Academy of Family Physicians, Colorado Springs, 

April, 2012; “Practical management approaches to fibromyalgia”, Oklahoma Academy of Family Physicians, Tulsa, OK, 

June, 2012; “Practical management approaches to fibromyalgia”,  Iowa Academy of Family Physicians annual meeting, Des Moines, IA.

October, 2012.  “FM: what it is and what it is not”, Women’s Healthcare Conference, Seattle.

May, 2011.  “Managing fibromyalgia in women”, AAPI Chapters of greater New York & New Jersey, Bridgewater, NJ.

October, 2010.  “Unraveling the mystery of fibromyalgia: the critical role of positional cervical cord compression (PC3)”, Kingston Hospital Education Centre, London.

October, 2009.  “Cervical spinal cord compression and fibromyalgia”, Grand Rounds, Evergreen Hospital, Kirkland, WA.

June, 2009.  “Autonomic regulation of RA: prediction of disease expression and anti-TNF treatment response”, Rheumatology Grand Rounds, Hospital for Special Surgery, New York.

April, 2009.  “Fibromyalgia, dysautonomia, hypermobility and positional myelopathy”, Pain and Hypermobility Syndromes, British Society for Rheumatology annual meeting, Glasgow.

December, 2008.  “FM: what it is, what it isn’t and what to do about it.” Guy’s Hospital, London.

September, 2006.  “Fibromyalgia and Positional Cervical Myelopathy: a novel an unrecognized co-morbidity”, National Fibromyalgia Research Association meeting on the Neurology of Fibromyalgia. Salem, OR.

June, 2006.  “Fibromyalgia Clinical Update”, Grand Rounds, Evergreen Hospital, Kirkland, WA

March, 2006. "Fibromyalgia and Dopamine”, National Fibromyalgia Association, Garden Grove, CA.

May, 2004.  “Central Autonomic Nervous System Regulation, Dopamine Agonists and Fibromyalgia”, Organization for Fatigue and Fibromyalgia Education and Research (OFFER), Salt Lake City, UT.

May, 2003.  “Update on Fibromyalgia: Dopamine Agonists”, Arthritis Foundation of Wisconsin, Madison, WI.

October, 2002.  “Neurology and New Treatment Modalities in Fibromyalgia”, National Fibromyalgia Research Association, Portland, OR